The Potential of Algae to Treat Chronic Inflammation

Seagriculture USA 2024

From the Archives

Chronic Inflammation

Dr. Dorit Avni, coordinator of Algae4IBD, MIGAL Galilee Research Institute

Inflammatory bowel disease, or IBD, is a set of diseases which cause chronic inflammation in the bowel, the most common being Crohn’s disease and ulcerative colitis. In all forms of this illness, its resulting bowel injury impairs organ functions and leads to severe pain, fatigue, depression and in some cases colon cancer. These symptoms impair the lives of more than 6.8 million people worldwide and, according to estimates, this illness is going to affect 8 million people by 2025.

Currently no cure exists, so available therapies focus on mitigating the inflammation and its symptoms. Some of the available treatments also cause side effects. Steroid-based medications lead to sleeping problems and increased appetite. Not every patient responds to treatment either, making removal of the affected organ parts their only option for a life with controlled IBD.

So, what if the cure for a chronic disease like IBD lies in our ocean, rivers, or lakes? The EU-funded Algae4IBD project will help to answer this question.

Algae4IBD project to research cures and treatments

Some algal compounds can be beneficial for our health. The anti-inflammatory compounds of Chlorella, among other things, make these algae a preferred source for food supplements. Consuming Chlorella could help reduce chronic inflammation.

Scientists expect more algae species to have similar health effects. Dr. Dorit Avni, Algae4IBD coordinator, an expert in immune modulation at the MIGAL Galilee Research Institute in Israel, is one of these scientists. “I think we just started to scratch the huge world of algae,” she says. “We know about some, but algae are a huge untapped reservoir with an infinite opportunity to find novel compounds. We found interesting anti-inflammatory compounds from algae that could have higher therapeutic activity than current standard (IBD) treatments.”

The Algae4IBD consortium is made up of academic and research institutes, hospitals, as well as companies with expertise in algae cultivation and extraction, food development and pharmaceuticals. It has 21 partners spread over 11 countries, with MIGAL from Israel as the coordinator. The researchers, companies and hospitals involved in the different stages of the project will use the biodiversity of algae, both micro and macro, as a wide source for bioactive compounds using state-of-the-art cultivation and extraction technologies for obtaining bio-active molecules.

Aside from developing new IBD medicines, the researchers from the Algae4IBD project are developing “smart food based on the compounds coming from algae. For example, bread that will be enriched with these relieving compounds,” said Dr. Avni. “With joint forces for four years, we definitely can provide the research base that will bring us either novel treatment through pharma or functional food.”

This project has received funding from the European Union’s HORIZON 2020 Research programme under the Grant Agreement no. 101000501

All rights reserved. Permission required to reprint articles in their entirety. Must include copyright statement and live hyperlinks. Contact david@algaeplanet.com. Algae Planet accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

Seagriculture USA 2024
AlgaeMetrics
Contact Phil Ganz

Subscribe

Breaking-News

  • July 19, 2024: A three-year development effort, the Ethiopian Bio and Emerging Technology Institute — in collaboration with the Ministry of Innovation and Technology and the Oromia Agricultural Research Institute — has recently launched the nation’s first microalgae (spirulina) research and production center at the Adami Tulu Agriculture Center, from an investment of 8.2 million birr ($142,600 USD). READ MORE...
  • July 17, 2024: A study from the University of New Hampshire has found that integrating farmed shrimp with oysters and seaweed in integrated multi-trophic aquaculture (IMTA) systems significantly reduces nitrogen levels. This could make shrimp farming more responsible and potentially support the growth of the U.S. industry. READ MORE...
  • July 15, 2024: Atlantic Sea Farms, a Maine-based leader in farmed seaweed, has harvested a record-breaking 1.3 million pounds of farmed seaweed in the 2024 harvest season. The company, which partners with fishing families to farm kelp in Maine, Rhode Island, and Alaska, has expanded both the supply of domestic line-grown kelp, as well as the market for their traceable, regeneratively farmed products to American consumers, chefs, and CPG companies since 2019. READ MORE...
  • July 12, 2024: Researchers have created tiny, vehicle-like structures which can be maneuvered by microscopic algae. The algae are caught in baskets attached to the micromachines, which have been carefully designed to allow them enough room to continue swimming. Two types of vehicles were created: the “rotator,” which spins like a wheel, and the “scooter,” which was intended to move in a forward direction but in tests moved more surprisingly. READ MORE...

Algae Europe 2024

A Beginner’s Guide